| 000 | 01160 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514004129.0 | ||
| 264 | 0 | _c20010823 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0022-1058 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFabrizio, M C | |
| 245 | 0 | 0 |
_aUse of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass. _h[electronic resource] |
| 260 |
_bThe journal of extra-corporeal technology _cMay 2001 |
||
| 300 |
_a117-25 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aBlood Coagulation Tests |
| 650 | 0 | 4 | _aCardiopulmonary Bypass |
| 650 | 0 | 4 |
_aEndopeptidases _xblood |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHirudin Therapy |
| 650 | 0 | 4 |
_aHirudins _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPennsylvania |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 773 | 0 |
_tThe journal of extra-corporeal technology _gvol. 33 _gno. 2 _gp. 117-25 |
|
| 999 |
_c11395161 _d11395161 |
||